A therosclerotic lesions contain elements of inflammatory reaction with fibroproliferative changes. An early atherosclerotic lesion consists largely of macrophages and T lymphocytes. With the advancement of the lesion, smooth muscle cells migrate, proliferate, and produce extracellular matrix components, presumably as part of a repair process of metabolic or physical injury and subsequent inflammation of blood vessels. 1 The repair process after injury is associated with the induction of immediate early genes such as c-fos and c-jun, followed by the production of various kinds of growth factors and cytokines.
Angiotensin II (Ang II) is a multifunctional octapeptide that increases contraction of blood vessels and induces hypertrophy and hyperplasia of vascular smooth muscle cells (VSMC). There are 2 isoforms for Ang II receptor, which are designated as type 1 receptor (AT 1 R) 2,3 and type 2 receptor (AT 2 R). 4, 5 Most of the cardiovascular effects of Ang II are ascribed to the AT 1 R. Ang II stimulates production of growth factors such as platelet-derived growth factor (PDGF) and transforming growth factor-␤ (TGF-␤) and matrix components such as collagen and fibronectin through the AT 1 R in VSMC. Several lines of evidence have suggested the important roles of Ang II in vascular cell growth and tissue remodeling following hypertension, vascular injury, and atherosclerosis. 6 -10 Recent findings showed that the AT 1 R couples to many intracellular signal transduction pathways. In common with many other growth factors, Ang II causes a rapid induction of the growth-associated immediate early gene expression. Stimulation of AT 1 R by Ang II elicits tyrosine phosphorylation and activates the mitogen-activated protein kinase (MAPK) pathway. [11] [12] [13] [14] [15] Understanding of the mechanism of these Ang II-stimulated signaling pathways is important because these signals eventually activate gene transcription of immediate early genes, growth factors, and extracellular matrix, resulting in hypertrophy or hyperplasia of VSMC.
Interleukin-6 (IL-6) has multiple biological activities, such as induction of B-cell differentiation, T-cell activation, induction of acute-phase protein such as C-reactive protein (CRP) and fibrinogen in the liver, and production of platelets. 16, 17 Ikeda et al 18 showed that IL-6 increased the proliferation of VSMC in a PDGF-dependent manner. IL-6 is secreted from macrophages, T cells, endothelial cells, mesangial cells, and VSMC. 18 -22 In terms of VSMC, IL-6 is secreted by stimulation of interleukin-1 23 and PDGF. 24 IL-6 mRNA was expressed in the atherosclerotic lesion of Watanabe heritable hyperlipidemic (WHHL) rabbits. 25 The plasma level of IL-6 is elevated in patients with unstable angina. 26 Although these studies suggest an important role of IL-6 in atherosclerosis, the mechanism and the source of IL-6 production are not understood. In addition, the effect of Ang II on IL-6 production has not been elucidated.
In this report we demonstrated that Ang II induced IL-6 expression in cultured rat VSMC through the AT 1 R. Deletion and mutational analysis of the promoter region of the IL-6 gene showed that cAMP-responsive element (CRE) plays an important role in Ang II-induced upregulation of IL-6 gene expression. 
Methods

Reagents
Cell Culture
VSMC were isolated from the thoracic aorta of Sprague-Dawley rats as described previously 27 and maintained in DMEM supplemented with 10% fetal bovine serum at 37°C in a humidified atmosphere of 95% air/5% CO 2 . Passages between 5 and 15 were used for the experiments. Cells were seeded in 6-cm tissue culture dishes or 24 well plates and cultured in DMEM with 10% fetal bovine serum for 4 days. Then the medium was changed to DMEM supplemented with 0.1% BSA. The cells were cultured for an additional 2 days and stimulated with Ang II for the indicated period.
Northern Blot Analysis
Total RNA was prepared by an acid guanidinium-phenol-chloroform extraction method. 28 Northern blot analysis was performed as described previously except that 20 g of total RNA was analyzed. 29 The hybridized membrane was stripped by boiling in 0.5% SDS solution and hybridized to a 32 P-labeled 18S ribosomal RNA probe to obtain a reference for the amount of applied RNA. The radioactivity of hybridized bands of IL-6 or 18S ribosomal RNA was quantified by a MacBAS bioimaging analyzer (FUJIFILM).
Deletion Mutants of Rat IL-6 Gene Promoter Region and Construction of Luciferase Fusion DNA Construct
A genomic DNA clone encoding the rat IL-6 promoter region 30 was obtained by the polymerase chain reaction technique with 5Ј primer (5Ј GTGGACAGAAAACCAGGGAC 3Ј) and 3Ј primer (5Ј CTGT-TCCTGAAGGGCAGATG 3Ј). The product of polymerase chain reaction, the IL-6 promoter region, was sequenced by the dideoxy chain termination method (Thermo Sequenase cycle sequencing kit, Amersham) after cloning into pBluescript (Stratagene). The promoter region of IL-6 gene was digested with restriction endonucleases. The 5Ј-end of the digested DNA fragments was blunted by Klenow enzyme or T4 DNA polymerase, and the 3Ј-end was digested with XhoI, which is located in the first exon of the rat IL-6 gene. Five deletion mutants (from No. 1 to No. 5) were cloned into the SmaI-XhoI site of pGL3 basic vector (Promega Corporation). Site-directed mutagenesis was performed according to the method of Higuchi et al. 31 In the deletion mutant No. 1, the wild-type sequence of CRE, ATGACGTCA, was altered to ATCGATCCA. Nucleotide sequences of the mutation were confirmed by DNA sequencing.
Transfection of IL-6 Promoter-Luciferase Fusion DNA Construct to VSMC Confluent VSMC were split by trypsin/EDTA solution, and 5ϫ10 5 cells were prepared in a 6-cm tissue culture dish. After 48 hours, 5 g of IL-6 promoter-luciferase fusion DNA and 2 g of ␤-galactosidase gene driven by an SV40 promoter-enhancer sequence were introduced to VSMC by the DEAE dextran method according to the manufacture's instructions (Promega Corporation). After transfection, the cells were cultured in DMEM with 10% FCS for 24 hours, washed twice with phosphate-buffered saline, and stimulated with 10 Ϫ6 mol/L of Ang II for 24 hours in DMEM with 0.1% BSA. The luciferase activity was measured as described previously. 29 The ␤-galactosidase activity in the same sample was measured spectrophotometrically according to Sambrook et al 32 and used to normalize the luciferase activity.
Quantification of Rat IL-6 by Sandwich ELISA
The medium of unstimulated or Ang II-stimulated VSMC was collected and centrifuged at 12 000 rpm for 1 minute. The supernatant was stored at Ϫ70°C until assay. ELISA for rat IL-6 was performed with a Cytoscreen ELISA kit (BioSourse International) according to the manufacture's instructions. Briefly, serial dilution of recombinant rat IL-6 and test samples were applied to a microtiter plate coated with an anti-rat IL-6 monoclonal antibody, and the incubation was done at 37°C for 3 hours. The solution was discarded, and wells were washed 4 times. Then biotinylated anti-rat IL-6 antibody solution was added. After the incubation at room temperature for 30 minutes and washing 4 times, streptavidin-horseradish peroxidase was added. After the incubation at room temperature for 30 minutes and washing 4 times, a stabilized chromogen, tetramethylbenzidine, was added. The plate was incubated at room temperature for 30 minutes in the dark, and the color was read spectrophotometrically at 450 nm.
Preparation of Nuclear Extracts and Gel Mobility Shift Assay
Nuclear extracts were prepared according to the methods described by Dignam et al 33 and Osborn et al. 34 Gel mobility shift assay was performed as described previously. 29 DNA probe (wild-type CRE: 5Ј-GCTAAATGACGTCACATT-3Ј) was labeled with 32 P. Ten micrograms of nuclear extracts was incubated with 1ϫ10 5 cpm of labeled DNA probe and 2 g of deoxyinosine-deoxycytidine heteropolymer in a buffer containing 20 mmol/L HEPES, pH 7.9, 50 mmol/L KCl, 1 mmol/L MgCl 2 , 5 mmol/L dithiothreitol, 1 mmol/L EDTA, 4% glycerol, and 50 mg/L BSA for 30 minutes at room temperature and electrophoresed on 5% acrylamide gel. Wildtype CRE or mutant CRE (5Ј-GCTAAATCGATCCACATT-3Ј) was added as a competitor. After electrophoresis, gels were dried and exposed to an x-ray film at Ϫ80°C.
Statistical Analysis
Statistical analyses were performed by 1-way or 2-way ANOVA and multiple comparison (Fisher) test if appropriate. A P value Ͻ0.05 was considered significant. Data were expressed as meanϮSE.
Results
Ang II-Increased IL-6 Production
VSMC were stimulated with Ang II, and the protein level of IL-6 in the supernatant was measured by sandwich ELISA. As shown in Figure 1A , the protein level of IL-6 in the tissue culture medium of Ang II (10 Ϫ7 mol/L)-stimulated VSMC was increased in a time-dependent manner. A small amount
Funakoshi et al Induction of IL-6 Expression by Ang II
of IL-6 was detected in the supernatant of unstimulated VSMC after 24 hours. A significant increase of IL-6 in the supernatant of Ang II-stimulated VSMC was observed after 6 hours. Next we examined the effect of isoform-specific antagonist for Ang II receptor on the enhancement of IL-6 expression. CV11974 (10 Ϫ5 mol/L), an AT 1 R-specific antagonist, inhibited the enhancement of IL-6 production by Ang II, but PD123319 (10 Ϫ5 mol/L), an AT 2 R-specific antagonist, had no significant effect. These results suggest that Ang II stimulates IL-6 production through the AT 1 R in VSMC. At 24 hours of stimulation, Ang II dose dependently increased IL-6 production ( Figure 1B ).
Enhancement of IL-6 mRNA Expression by Ang II
We examined the time course of Ang II-induced IL-6 mRNA expression (Figure 2 ). Two species of IL-6 gene transcript were detected (Figure 2A ). The most abundant transcript was Ϸ1.3 kb in length, and the less abundant transcript was Ϸ2.4 kb. The 2 IL-6 mRNA species are generated by an alternative polyadenylation. 30 For the quantification of IL-6 mRNA, the radioactivities of both mRNA species were taken into account. As seen in Figure  2 , a biphasic increase of IL-6 mRNA by Ang II was observed. The first peak was at 30 minutes after Ang II stimulation. Then the expression level of IL-6 mRNA was decreased, and the second peak was at 12 to 24 hours after Ang II stimulation.
VSMC were incubated with various concentrations of Ang II for 30 minutes. The expression of IL-6 mRNA by Ang II was increased dose dependently ( Figure 3 ). We also examined the Ang II receptor responsible for IL-6 mRNA expression by using an isoform-specific antagonist. CV11974 completely abolished the IL-6 mRNA induction by Ang II; however, PD 123319 showed no effect ( Figure 3 ). This result suggests that Ang II induces IL-6 mRNA expression through the AT 1 R and is consistent with the results of IL-6 protein production. 
Intracellular Signals in Ang II-Induced IL-6 Expression
We examined the signaling pathway of Ang II important for the induction of IL-6 gene expression (Figure 4) . Protein kinase C (PKC) activation 35 37 Pretreatment with genistein (10 Ϫ5 mol/L), which inhibits tyrosine kinase, and PD98059 (10 Ϫ5 mol/L), which inhibits activation of MAPK kinase, abolished the effect of Ang II on the induction of IL-6 mRNA. These results suggest that Ang II-induced tyrosine phosphorylation and MAPK activation also play important roles in the activation of IL-6 gene expression.
Promoter Activity of IL-6 Gene
To determine the promoter region responsible for the induction of IL-6 gene expression by Ang II, deletion Figure 5 . Deletion analysis of IL-6 gene promoter. A, As illustrated (top), there are various consensus cis DNA elements such as glucocorticoid-responsive element (GRE) (Ϫ559 to Ϫ554 bp and Ϫ444 to Ϫ439 bp), AP-1 (Ϫ237 to Ϫ232 bp), CRE (Ϫ156 to Ϫ149 bp), NF-IL6 (binding site for NF-IL6, Ϫ147 to Ϫ137 bp), NF-B (binding site for NF-B, Ϫ62 to Ϫ44 bp), and TATA box (Ϫ18 to Ϫ13 bp). Five deletion mutants of the IL-6 gene promoter were prepared by digestion with restriction endonucleases and fused to a luciferase gene (Luc). B, Five micrograms of each deletion mutant of promoterluciferase fusion DNA construct was introduced into cultured VSMC by the DEAE dextran method. Twenty-four hours after transfection, the culture medium was changed to DMEM with 0.1% BSA, and VSMC were cultured without or with Ang II (10 Ϫ6 mol/L) for an additional 24 hours. Cell lysates were extracted, and luciferase activities were measured. The luciferase activity was standardized by the ␤-galactosidase activity expressed by cotransfected LacZ gene expression plasmid (2 g). The normalized luciferase activity in unstimulated construct No. 1 was designated as 1.0, and relative luciferase activity is shown. Date are shown as meanϮSE of 9 independent assays. 
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analysis of the promoter region was performed. We constructed luciferase expression vectors with various lengths of the promoter region of the IL-6 gene ( Figure 5A ). Luciferase activity was measured after 24 hours of Ang II (10 Ϫ6 mol/L) stimulation ( Figure 5B ). Ang II stimulated luciferase activity by Ϸ2-fold in constructs of No. 1, No. 2, and No. 3. The response to Ang II was not observed in the construct that lacked the DNA segment between -581 and -150 bp (No. 4). In this DNA segment, several consensus cis DNA elements such as glucocorticoid response element, AP-1, and CRE are present. Among these elements, the AP-1 and the CRE (also known as a multiple response element) were reported to be important for basal and lipopolysaccharide-stimulated IL-6 gene expression. 38 Because downregulation of PKC by prolonged exposure to PMA or a PKC inhibitor showed no effect on Ang II-induced enhancement of IL-6 gene expression, we assumed that the AP-1 site is not critical. Therefore, we introduced a mutation into the CRE site. The luciferase activity of luciferase expression plasmid driven by IL-6 gene promoter with mutation in the CRE site was not enhanced by Ang II stimulation ( Figure 6 ). This suggests that the CRE site in the IL-6 gene promoter is essential for Ang II-induced upregulation. We also examined the effect of PD98059 on IL-6 promoter activity. Pretreatment with PD98059 strongly inhibited Ang II-induced upregulation.
Induction of CREB by Ang II
Next we examined the DNA binding protein bound to the CRE site using gel mobility shift assay ( Figure 7 ). When nuclear extracts from Ang II-stimulated VSMC were used, DNA binding protein (arrow 2) was increased compared with unstimulated VSMC (lanes 1 to 3) . Specificity of the binding was confirmed by adding 100 times molar excess of nonlabeled probe that eliminates this band (lane 4). When oligonucleotide with mutation in the CRE site was added as a competitor, this band did not fade (lane 5). When the antibody against CREB was added (lane 6), the band was supershifted (the shifted band is indicated by arrow 1). However, when an irrelevant antibody (antibody against Stat 3) was added (lane 7), the band was not supershifted. These results suggested that Ang II induces CREB bound to the CRE site of the IL-6 gene promoter.
Discussion
We showed the following: (1) Ang II stimulated the expression of IL-6 through the AT 1 R in VSMC; (2) the induction of IL-6 expression by Ang II was dependent on intracellular Ca 2ϩ , tyrosine phosphorylation, and MAPK kinase and independent of PKC or extracellular Ca 2ϩ ; (3) CRE in the promoter region of the IL-6 gene plays an important role in Ang II-induced upregulation.
Previous studies suggested that a Ca 2ϩ -dependent signaling mechanism plays an important role in Ang IIinduced activation of MAPK through the AT 1 R. 37 Chelation of intracellular Ca 2ϩ by BAPTA-AM suppressed Ang II-induced IL-6 mRNA expression. In contrast, chelation of extracellular Ca 2ϩ by EGTA itself enhanced IL-6 mRNA expression and did not inhibit Ang II-induced upregulation. Several reports showed that various Ca 2ϩ channel blockers increased the expression of IL-6 mRNA in human VSMC, 39 human mesangial cells, 40 and peripheral blood mononuclear cells. 41 EGTA may exert an effect similar to that of the Ca 2ϩ channel blocker. However, the mechanism by which EGTA and Ca 2ϩ channel blocker stimulate IL-6 gene expression remains unclear. Pretreatment with PD98059 or genistein completely inhibited Ang II-induced IL-6 expression. Recently, Eguchi et al 37 showed that Ang II-induced MAPK activation is dependent on Ca 2ϩ /calmodulin-sensitive tyrosine phosphorylation. Our results were consistent with their results and suggest that the downstream signal(s) of MAPK is important for IL-6 gene activation by Ang II.
There are several important regulatory cis DNA elements such as AP-1, CRE, nuclear factor-IL-6 (NF-IL6), and nuclear factor-B (NF-B) in the promoter region of the IL-6 gene. These promoter elements are conserved among species such as mouse, 42 rat, 30 and human 43 and regulate IL-6 gene expression in a cell type-specific manner. AP-1, NF-B, and NF-IL6 are required for IL-6 Figure 6 . Role of CRE site and MAPK in Ang II-induced IL-6 promoter activity. A, Five micrograms of wild-type promoterluciferase fusion DNA (Ϫ1039) or mutant promoter-luciferase fusion DNA (Ϫ1039 with mutation in CRE site) was introduced to VSMC by the DEAE dextran method. B, Twenty-four hours after transfection, the culture medium was changed to DMEM with 0.1% BSA, and VSMC pretreated with or without PD98059 (10 Ϫ5 mol/L) were stimulated with Ang II (10 Ϫ6 mol/L) for 24 hours. Cell lysates were extracted, and luciferase activity was measured. Luciferase activity was standardized by the ␤-galactosidase activity expressed by cotransfected LacZ gene expression plasmid (2 g). Data are shown as meanϮSE of 9 independent assays. The normalized luciferase activity in VSMC without Ang II stimulation was designated as 1.0. **PϽ0.05 versus Ang II (Ϫ).
gene expression in monocytes. 38 NF-B is sufficient for expression in the T-cell line. 44 However, regulatory elements important for expression in VSMC have not been investigated. Although the basal expression of IL-6 mRNA in quiescent VSMC is very weak, deletion analysis showed that the DNA segment between Ϫ150 and -27 bp is important for basal expression because luciferase activity was greatly reduced by deletion of this DNA segment ( Figure 5 ; compare the luciferase activity of No. 5 construct with that of No. 4). In this DNA segment, NF-B, NF-IL6, and GATA are present and probably are important for the basal expression of IL-6 gene in VSMC. In terms of the response to Ang II, the DNA segment between -581 and -150 bp is essential. Mutational analysis showed that the CRE site in this DNA segment is essential for the response to Ang II. However, transcription factors are known to activate gene transcription in a cooperative manner. Therefore, the cooperation of CREB with other transcription factors such as AP-1, NF-IL6, or NF-B may play a role, and this possibility is not excluded in this study. Recently, Xing et al 45 reported that MAPK-activated p90 rsk2 phosphorylates and activates CREB. Because Ang II-induced activation of IL-6 gene transcription is inhibited by a MAPK kinase inhibitor, it is possible that Ang II activates the MAPK-p90 rsk2 -CREB pathway and upregulates IL-6 gene transcription.
It is known that protein kinase A, the calmodulindependent protein kinases, 46 p90 rsk2 , and MAPK-activated protein kinase-2 47 phosphorylate CREB at serine-133, which is a key regulatory site controlling transcriptional activity in the response to a variety of extracellular signals, including growth factors and neurotropins. However, Chawla et al 48 reported a dissociation between CREB phosphorylation on serine-133 and CRE-dependent transcription. Therefore, at this point it is not clear that increased binding of CREB by gel mobility shift assay correlates with activation of CRE-dependent transcription of IL-6 gene promoter.
We observed a biphasic increase of IL-6 mRNA by Ang II, as shown in Figure 2 . Because Ang II induces production of many growth factors in VSMC, we assumed that the second peak was induced by Ang II-induced growth factors. To test this possibility, VSMC were incubated with cycloheximide (10 Ϫ8 mol/L, 30 minutes), which is a protein synthesis inhibitor, and incubated with or without 10 Ϫ6 mol/L of Ang II for 30 minutes or 24 hours. Cycloheximide increased basal mRNA expression at 30 minutes or 24 hours. The induction of IL-6 mRNA by cycloheximide has been reported. 41 The response to Ang II in the presence of cycloheximide was preserved at both incubation periods, suggesting that the IL-6 mRNA expression by Ang II dose not require de novo protein synthesis (data not shown).
Previous studies have shown that IL-6 increases the number of platelets in the circulation 17 and IL-6 activates platelets through arachidonic acid metabolism in vitro. 49 Burstein 50 reported that IL-6 increased plasma fibrinogen and decreased free protein S concentration. These IL-6 -induced modifications of platelet and the coagulant phase of the clotting mechanism may lead to pathological thrombosis and instability of plaque. In an experimental model, Ikeda et al 25 reported that IL-6 gene transcript was expressed in the atherosclerotic plaque of WHHL rabbit. However, the role of Ang II in the expression of IL-6 in WHHL rabbit was not defined. Recently, Nickenig et al 51 reported that LDL increased AT 1 R mRNA in VSMC by increasing its stability and resulted in the elevation of functional response to Ang II. Thus, it is possible that AT 1 R in the WHHL rabbit plays a pivotal role in the induction of IL-6 transcript in atheromatous plaque.
Although it is not clear from this study that Ang II regulates IL-6 production in vivo, inhibition of Ang IIinduced IL-6 production may be one of the mechanism by which an angiotensin-converting enzyme inhibitor or an AT 1 R antagonist prevents neointimal formation in the balloon injury model of atherosclerosis. Our data clearly showed the role of Ang II in IL-6 production in VSMC, suggesting that Ang II may mediate the inflammatory process in blood vessels. Gel mobility shift analysis of nuclear protein of VSMC. Nuclear protein from unstimulated (lane 1) or Ang II (lanes 2 to 7)-stimulated VSMC and 32 P-labeled DNA (wildtype CRE) probe were mixed and incubated as described in Methods. Nuclear extracts from VSMC stimulated with Ang II for 15 minutes (lanes 2, 6, and 7) and for 30 minutes (lanes 3 to 5) were used. One hundred times molar excess of unlabeled CRE oligonucleotide (lane 4) and unlabeled mutant (mut) CRE oligonucleotide (lane 5) were added to the reaction mixture. Antibodies (Ab) for CREB (lane 6) or Stat 3 (lane 7) were added to the reaction mixture. Then the mixture was electrophoresed in an acrylamide gel. Arrow 2 indicates specific binding, because this band was eliminated by 100 times molar excess of unlabeled wild-type CRE oligonucleotide and supershifted by the addition of CREB antibody. The same results were obtained in other independent experiments (nϭ3); a representative autoradiography is shown.
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